¡Ya estamos en ! Descubre más
27.94 USD
-0.56
1.96%
Al cierre Actualizado 16 nov, 11:36 a.m. EST
1 día
-1.96%
5 días
52.26%
1 mes
-1.96%
3 meses
-1.96%
6 meses
-1.96%
En lo que va del año
-1.96%
1 año
-1.96%
5 años
-1.96%
10 años
-1.96%
 

Acerca de: Windward Bio Group AG is a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, including asthma, COPD, and atopic dermatitis. Its flagship program is WIN378, a potentially novel, long-acting, anti-TSLP monoclonal antibody. The pipeline also includes WIN027, a clinical-stage, long-acting anti-TSLPxIL-13 bi-specific, which has therapeutic application across immunological diseases.

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 0%
Neutral 0%
Negativo 0%

No hemos recibido artículos de noticias recientes sobre WWB.

Gráficos de precios implementados con Lightweight Charts™